PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard (FR0011464452 – ALSGD), an innovative company that designs, develops and markets disposable medical devices intended to make spine surgery safer, today announced the closing of a €1.6 million private placement capital increase and the launch of a €1.8 million public offering partially eligible for French TEPA act provisions.
Pierre Jérôme, CEO and Co-founder of SpineGuard, said: "This capital increase that we wish to open broadly will enable us to continue accelerating our sales growth. Our growth strategy is clear: complete the development of ‘smart screws’ with our partners, start marketing them quickly and continue expanding the scope of our DSG technology platform to make it an undisputed standard of care, while making SpineGuard profitable."
Help employers find you! Check out all the jobs and post your resume.
Pierre Jérôme, CEO and Co-founder of SpineGuard, said: "This capital increase that we wish to open broadly will enable us to continue accelerating our sales growth. Our growth strategy is clear: complete the development of ‘smart screws’ with our partners, start marketing them quickly and continue expanding the scope of our DSG technology platform to make it an undisputed standard of care, while making SpineGuard profitable."
Help employers find you! Check out all the jobs and post your resume.
